We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ZLAB market cap is 2.14B. The company's latest EPS is USD -1.62 and P/E is -11.83.
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 106.49M | 109.98M | 116.1M | 127.6M | 99.61M |
| Operating Income | -56.31M | -54.9M | -48.82M | -69.41M | -69.39M |
| Net Income | -48.44M | -40.73M | -35.96M | -50.41M | -51.02M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 144.31M | 215.04M | 266.72M | 398.99M | 460.16M |
| Operating Income | -700.06M | -404.36M | -376.57M | -282.12M | -229.43M |
| Net Income | -704.47M | -443.29M | -334.62M | -257.1M | -175.54M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.17B | 1.16B | 1.16B | 1.17B | 1.1B |
| Total Liabilities | 362.58M | 372.37M | 399M | 456.88M | 433.76M |
| Total Equity | 810.75M | 791.74M | 759.95M | 715.5M | 661.98M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.61B | 1.22B | 1.04B | 1.19B | 1.17B |
| Total Liabilities | 230M | 174.55M | 240.18M | 344.86M | 456.88M |
| Total Equity | 1.38B | 1.05B | 796.12M | 840.9M | 715.5M |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -61.7M | -31.02M | -32.04M | -26.02M | -11.91M |
| Investing | 326.13M | -2.92M | -4.05M | -11.3M | -22.29M |
| Financing | 43.14M | 8.85M | 20.79M | -430k | 5.57M |
| Year End December 31 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -549.23M | -367.64M | -198.18M | -214.87M | -150.79M |
| Investing | 249.96M | 420.02M | -10.78M | -375.19M | 307.87M |
| Financing | 820.2M | -1.73M | -6.43M | 349.89M | 72.35M |
| Market Cap | 2.144B |
| Price to Earnings Ratio | -11.83 |
| Price to Sales Ratio | 4.74 |
| Price to Cash Ratio | 5.87 |
| Price to Book Ratio | 3.21 |
| Dividend Yield (LTM) | N/A |
| Shares Outstanding | 112.35M |
| Average Volume (1 week) | 693.82k |
| Average Volume (1 Month) | 994.09k |
| 52 Week Change | - |
| 52 Week High | 41.20 |
| 52 Week Low | 15.96 |
| Spread (Intraday) | 0.8 (4.15%) |
| Company Name | Zai Lab Ltd |
| Address |
Building B Pudong, Shanghai Province 201203 |
| Website | https://www.zailaboratory.com |
| Industry | Biotechnology & Life Sciences |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.